{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:45:15Z","timestamp":1782603915853,"version":"3.54.5"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11926-022-01088-0","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T09:19:14Z","timestamp":1663751954000},"page":"323-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["A Spotlight on Drug-Induced Vasculitis"],"prefix":"10.1007","volume":"24","author":[{"given":"Kinanah","family":"Yaseen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Nevares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"issue":"1","key":"1088_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"\u2022\u2022 Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1\u201311. https:\/\/doi.org\/10.1002\/art.37715. International Consensus guidelines on the classification of different vasculitides.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"1088_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1345\/aph.1A124","volume":"36","author":"SM ten Holder","year":"2002","unstructured":"ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother. 2002;36(1):130\u201347. https:\/\/doi.org\/10.1345\/aph.1A124.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1088_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/BOR.0b013e3282f1331f","volume":"20","author":"A Wiik","year":"2008","unstructured":"Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol. 2008;20(1):35\u20139. https:\/\/doi.org\/10.1097\/BOR.0b013e3282f1331f.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1088_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01100.x","volume":"14","author":"Y Gao","year":"2009","unstructured":"\u2022\u2022 Gao Y, Zhao MH. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Carlton Vic. 2009;14(1):33\u201341. https:\/\/doi.org\/10.1111\/j.1440-1797.2009.01100.x. One of the earliest reviews focusing on drug induced-AAV.","journal-title":"Nephrol Carlton Vic."},{"issue":"5","key":"1088_CR5","first-page":"230","volume":"22","author":"BU Ihle","year":"1984","unstructured":"Ihle BU, Whitworth JA, Dowling JP, Kincaid-Smith P. Hydralazine and lupus nephritis. Clin Nephrol. 1984;22(5):230\u20138.","journal-title":"Clin Nephrol"},{"issue":"6","key":"1088_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/096120339400300608","volume":"3","author":"RA McKinnon","year":"1994","unstructured":"McKinnon RA, Nebert DW. Possible role of cytochromes P450 in lupus erythematosus and related disorders. Lupus. 1994;3(6):473\u20138. https:\/\/doi.org\/10.1177\/096120339400300608.","journal-title":"Lupus"},{"issue":"1","key":"1088_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","volume":"26","author":"WF Pendergraft","year":"2014","unstructured":"Pendergraft WF, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol. 2014;26(1):42\u20139. https:\/\/doi.org\/10.1097\/BOR.0000000000000014.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"1088_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/art.10833","volume":"48","author":"C Deng","year":"2003","unstructured":"Deng C, Lu Q, Zhang Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 2003;48(3):746\u201356. https:\/\/doi.org\/10.1002\/art.10833.","journal-title":"Arthritis Rheum"},{"issue":"246","key":"1088_CR9","first-page":"845","volume":"65","author":"GI Russell","year":"1987","unstructured":"Russell GI, Bing RF, Jones JA, Thurston H, Swales JD. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. Q J Med. 1987;65(246):845\u201352.","journal-title":"Q J Med"},{"issue":"1","key":"1088_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1684\/ejd.2016.2881","volume":"27","author":"CM Magro","year":"2017","unstructured":"Magro CM, Momtahen S, Harp J. The distinctive histopathology of hydralazine-associated ANCA positive vasculitis: in vivo demonstration of NETosis. Eur J Dermatol EJD. 2017;27(1):91\u20132. https:\/\/doi.org\/10.1684\/ejd.2016.2881.","journal-title":"Eur J Dermatol EJD"},{"issue":"3","key":"1088_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/art.40372","volume":"70","author":"JA Irizarry-Caro","year":"2018","unstructured":"Irizarry-Caro JA, Carmona-Rivera C, Schwartz DM, Khaznadar SS, Kaplan MJ, Grayson PC. Brief Report: Drugs implicated in systemic autoimmunity modulate neutrophil extracellular trap formation. Arthritis Rheumatol Hoboken NJ. 2018;70(3):468\u201374. https:\/\/doi.org\/10.1002\/art.40372.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"1088_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5152\/eurjrheum.2017.17075","volume":"5","author":"H Timlin","year":"2018","unstructured":"\u2022\u2022 Timlin H, Liebowitz JE, Jaggi K, Geetha D. Outcomes of hydralazine induced renal vasculitis. Eur J Rheumatol. 2018;5(1):5\u20138. https:\/\/doi.org\/10.5152\/eurjrheum.2017.17075. Important study evaluated the long-term renal outcomes in patients with HAV.","journal-title":"Eur J Rheumatol."},{"issue":"3","key":"1088_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10165-009-0168-y","volume":"19","author":"N Yokogawa","year":"2009","unstructured":"\u2022\u2022 Yokogawa N, Vivino FB. Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol. 2009;19(3):338\u201347. https:\/\/doi.org\/10.1007\/s10165-009-0168-y. Extensive review compared hydralazine-induced lupus and hydralazine-associated AAV.","journal-title":"Mod Rheumatol."},{"issue":"2","key":"1088_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","volume":"43","author":"HK Choi","year":"2000","unstructured":"\u2022\u2022 Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43(2):405\u201313. https:\/\/doi.org\/10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5.\u00a0Retrospective study that determined the prevalence of exposure to hydralazine, propylthiouracil and other drugs among 30 patients with vasculitis and the highest titers of anti-MPO antibodies detected at the study site laboratory.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"1088_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.semarthrit.2018.01.005","volume":"48","author":"B Kumar","year":"2018","unstructured":"\u2022\u2022 Kumar B, Strouse J, Swee M, Lenert P, Suneja M. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis. Semin Arthritis Rheum. 2018;48(2):283\u20137. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.005. Important retrospective study described overlapping features between hydralazine-induced lupus and hydralazine associated AAV.","journal-title":"Semin Arthritis Rheum."},{"key":"1088_CR16","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Aeddula NR, Pathireddy S, Ansari A, Juran PJ. Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary\u2013renal syndrome. BMJ Case Rep. Published online November 8, 2018:bcr-2018\u2013227161. https:\/\/doi.org\/10.1136\/bcr-2018-227161.\u00a0Extensive review of literature that described\u00a0 pulmonary-renal syndrome related to HAV.","DOI":"10.1136\/bcr-2018-227161"},{"key":"1088_CR17","unstructured":"\u2022\u2022 Almaaitah S, Yaseen K, Jin Y, Hajj-Ali R. Long term outcome of hydralazine-associated vasculitis. In: Vol 71.\u00a02019. https:\/\/acrabstracts.org\/abstract\/long-term-outcome-of-hydralazine-associated-vasculitis\/. Accessed 11 Apr\u00a02022.\u00a0Recent abstract of a retroscpective study done at a large vasculitis center presented at the American College of Rheumatology described long term outcomes of HAV."},{"issue":"1","key":"1088_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/art.20927","volume":"53","author":"MC Slot","year":"2005","unstructured":"Slot MC, Links TP, Stegeman CA, Tervaert JWC. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study. Arthritis Rheum. 2005;53(1):108\u201313. https:\/\/doi.org\/10.1002\/art.20927.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1088_CR19","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1210\/jc.2002-021383","volume":"88","author":"M Gum\u00e0","year":"2003","unstructured":"Gum\u00e0 M, Salinas I, Reverter JL, et al. Frequency of antineutrophil cytoplasmic antibody in graves\u2019 disease patients treated with methimazole. J Clin Endocrinol Metab. 2003;88(5):2141\u20136. https:\/\/doi.org\/10.1210\/jc.2002-021383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1088_CR20","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1002\/art.34619","volume":"64","author":"D Nakazawa","year":"2012","unstructured":"Nakazawa D, Tomaru U, Suzuki A, et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculiti. Arthritis Rheum. 2012;64(11):3779\u201387. https:\/\/doi.org\/10.1002\/art.34619.","journal-title":"Arthritis Rheum"},{"issue":"21","key":"1088_CR21","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1056\/NEJM200505263522120","volume":"352","author":"E Lubin","year":"2005","unstructured":"Lubin E. Antithyroid drugs. N Engl J Med. 2005;352(21):2246\u20137 (author reply 2246-2247).","journal-title":"N Engl J Med."},{"issue":"3","key":"1088_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3899\/jrheum.110931","volume":"39","author":"YX Chen","year":"2012","unstructured":"Chen YX, Zhang W, Chen XN, et al. Propylthiouracil-induced Antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study. J Rheumatol. 2012;39(3):558. https:\/\/doi.org\/10.3899\/jrheum.110931.","journal-title":"J Rheumatol"},{"issue":"12","key":"1088_CR23","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1089\/thy.2017.0468","volume":"27","author":"J Yang","year":"2017","unstructured":"\u2022\u2022 Yang J, Yao LP, Dong MJ, et al. Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with graves\u2019 disease: a median 38-month retrospective cohort study from a single institution in China. Thyroid Off J Am Thyroid Assoc. 2017;27(12):1469\u201374. https:\/\/doi.org\/10.1089\/thy.2017.0468. Single retroscpective study reported clinical presenation and outcomes of propylthiouracil-induced AAV.","journal-title":"Thyroid Off J Am Thyroid Assoc."},{"issue":"6","key":"1088_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5414\/CN109364","volume":"89","author":"J Hasegawa","year":"2018","unstructured":"Hasegawa J, Hoshino J, Sekine A, et al. Clinical and histological features of antineutrophil cytoplasmic antibody-associated vasculitis related to antithyroid drugs. Clin Nephrol. 2018;89(6):438\u201344. https:\/\/doi.org\/10.5414\/CN109364.","journal-title":"Clin Nephrol."},{"issue":"10","key":"1088_CR25","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/rheumatology\/ken321","volume":"47","author":"Y Gao","year":"2008","unstructured":"Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatol Oxf Engl. 2008;47(10):1515\u201320. https:\/\/doi.org\/10.1093\/rheumatology\/ken321.","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"1088_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.mayocp.2012.03.010","volume":"87","author":"KC Lee","year":"2012","unstructured":"Lee KC, Ladizinski B, Federman DG. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012;87(6):581\u20136. https:\/\/doi.org\/10.1016\/j.mayocp.2012.03.010.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1088_CR27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1046\/j.1365-2133.1999.02833.x","volume":"140","author":"F Rongioletti","year":"1999","unstructured":"Rongioletti F, Ghio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol. 1999;140(5):948\u201351. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.02833.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1088_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/clpt.2010.156","volume":"88","author":"A Chang","year":"2010","unstructured":"Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88(3):408\u201311. https:\/\/doi.org\/10.1038\/clpt.2010.156.","journal-title":"Clin Pharmacol Ther"},{"key":"1088_CR29","doi-asserted-by":"publisher","unstructured":"Nitro L, Pipolo C, Fadda GL, et al. Distribution of cocaine-induced midline destructive lesions: systematic review and classification. Eur Arch Otorhinolaryngol. Published online February 9, 2022. https:\/\/doi.org\/10.1007\/s00405-022-07290-1","DOI":"10.1007\/s00405-022-07290-1"},{"issue":"12","key":"1088_CR30","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2215\/CJN.03440411","volume":"6","author":"MM McGrath","year":"2011","unstructured":"\u2022\u2022 McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol CJASN. 2011;6(12):2799\u2013805. https:\/\/doi.org\/10.2215\/CJN.03440411. Important retroscpective study at a large vasculitis center described clinical characteristics, laboratory findings and outcomes of cocaine- induced AAV.","journal-title":"Clin J Am Soc Nephrol CJASN."},{"issue":"1","key":"1088_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jbspin.2017.05.022","volume":"85","author":"A N\u00e9el","year":"2018","unstructured":"N\u00e9el A, Agard C, Hamidou M. Vasculitides induced by cocaine and\/or levamisole. Joint Bone Spine. 2018;85(1):9\u201314. https:\/\/doi.org\/10.1016\/j.jbspin.2017.05.022.","journal-title":"Joint Bone Spine."},{"issue":"4","key":"1088_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/rheumatology\/kew256","volume":"56","author":"C Lood","year":"2017","unstructured":"Lood C, Hughes GC. Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity. Rheumatol Oxf Engl. 2017;56(4):638\u201343. https:\/\/doi.org\/10.1093\/rheumatology\/kew256.","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"1088_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1309\/AJCPOPQNBP5THKP1","volume":"133","author":"DR Czuchlewski","year":"2010","unstructured":"Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010;133(3):466\u201372. https:\/\/doi.org\/10.1309\/AJCPOPQNBP5THKP1.","journal-title":"Am J Clin Pathol."},{"issue":"11","key":"1088_CR34","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00296-019-04410-9","volume":"39","author":"F L\u00f6tscher","year":"2019","unstructured":"L\u00f6tscher F, Krusche M, Ruffer N, Kubacki T, Person F, K\u00f6tter I. Cocaine-induced ANCA-associated renal disease: a case-based review. Rheumatol Int. 2019;39(11):2005\u201314. https:\/\/doi.org\/10.1007\/s00296-019-04410-9.","journal-title":"Rheumatol Int"},{"key":"1088_CR35","doi-asserted-by":"publisher","unstructured":"Chandra T, Tabanor-Gayle JA, Lakshminarayanan S. Adalimumab-induced anti-neutrophilic cytoplasmic antibody vasculitis: a rare complication of an increasingly common treatment. Cureus.\u00a02019.\u00a0https:\/\/doi.org\/10.7759\/cureus.5598.","DOI":"10.7759\/cureus.5598"},{"issue":"2","key":"1088_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1378\/chest.110.2.556","volume":"110","author":"SM Salerno","year":"1996","unstructured":"Salerno SM, Ormseth EJ, Roth BJ, Meyer CA, Christensen ED, Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener\u2019s granulomatosis. Chest. 1996;110(2):556\u20139. https:\/\/doi.org\/10.1378\/chest.110.2.556.","journal-title":"Chest"},{"issue":"1","key":"1088_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/03009740701607117","volume":"37","author":"NHAM Denissen","year":"2008","unstructured":"Denissen NHAM, Peters JGP, Masereeuw R, Barrera P. Can sulfasalazine therapy induce or exacerbate Wegener\u2019s granulomatosis? Scand J Rheumatol. 2008;37(1):72\u20134. https:\/\/doi.org\/10.1080\/03009740701607117.","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"1088_CR38","first-page":"743","volume":"16","author":"HK Choi","year":"1998","unstructured":"Choi HK, Merkel PA, Niles JL. ANCA-positive vasculitis associated with allopurinol therapy. Clin Exp Rheumatol. 1998;16(6):743\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 2","key":"1088_CR39","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1007\/s10067-008-1020-z","volume":"27","author":"M Haroon","year":"2008","unstructured":"Haroon M, Devlin J. A case of ANCA-associated systemic vasculitis induced by atorvastatin. Clin Rheumatol. 2008;27(Suppl 2):S75-77. https:\/\/doi.org\/10.1007\/s10067-008-1020-z.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1088_CR40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5527\/wjn.v5.i6.547","volume":"5","author":"S Gadde","year":"2016","unstructured":"Gadde S, Lee B, Kidd L, Zhang R. Antineutrophil cytoplasmic antibodies crescentic allograft glomerulonephritis after sofosbuvir therapy. World J Nephrol. 2016;5(6):547. https:\/\/doi.org\/10.5527\/wjn.v5.i6.547.","journal-title":"World J Nephrol"},{"issue":"5","key":"1088_CR41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.ajkd.2007.05.026","volume":"50","author":"F Bienaim\u00e9","year":"2007","unstructured":"Bienaim\u00e9 F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis Off J Natl Kidney Found. 2007;50(5):821\u20135. https:\/\/doi.org\/10.1053\/j.ajkd.2007.05.026.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"5","key":"1088_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5414\/CN108763","volume":"85","author":"Y Lee","year":"2016","unstructured":"Lee Y, Lee ST, Cho H. D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson\u2019s disease. Clin Nephrol. 2016;85(5):296\u2013300. https:\/\/doi.org\/10.5414\/CN108763.","journal-title":"Clin Nephrol"},{"issue":"6","key":"1088_CR43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/rheumatology\/kew063","volume":"55","author":"RRH van den Brom","year":"2016","unstructured":"van den Brom RRH, Abdulahad WH, Rutgers A, et al. Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition. Rheumatol Oxf Engl. 2016;55(6):1143\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kew063.","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"1088_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/rheumatology\/kez235","volume":"59","author":"M Villarreal-Compagny","year":"2020","unstructured":"Villarreal-Compagny M, Iglesias P, Marco-Hern\u00e1ndez J, et al. ANCA-associated vasculitic neuropathy during treatment with ipilimumab. Rheumatol Oxf Engl. 2020;59(1):251\u20132. https:\/\/doi.org\/10.1093\/rheumatology\/kez235.","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"1088_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.carpath.2014.01.002","volume":"23","author":"CD Tan","year":"2014","unstructured":"Tan CD, Smith A, Rodriguez ER. Systemic necrotizing vasculitis induced by isoniazid. Cardiovasc Pathol Off J Soc Cardiovasc Pathol. 2014;23(3):181\u20132. https:\/\/doi.org\/10.1016\/j.carpath.2014.01.002.","journal-title":"Cardiovasc Pathol Off J Soc Cardiovasc Pathol"},{"issue":"1","key":"1088_CR46","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1097\/MJT.0000000000000006","volume":"23","author":"F Kheir","year":"2016","unstructured":"Kheir F, Daroca P, Lasky J. Phenytoin-associated granulomatous pulmonary vasculitis. Am J Ther. 2016;23(1):e311-314. https:\/\/doi.org\/10.1097\/MJT.0000000000000006.","journal-title":"Am J Ther"},{"issue":"46","key":"1088_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004988","volume":"95","author":"A Mirouse","year":"2016","unstructured":"Mirouse A, Savey L, Domont F, et al. Systemic vasculitis associated with vemurafenib treatment: Case report and literature review. Medicine (Baltimore). 2016;95(46): e4988. https:\/\/doi.org\/10.1097\/MD.0000000000004988.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1088_CR48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3346\/jkms.2014.29.2.198","volume":"29","author":"Y Kang","year":"2014","unstructured":"Kang Y, Park JSU, Ha YJ, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Sch\u00f6nlein Purpura. J Korean Med Sci. 2014;29(2):198. https:\/\/doi.org\/10.3346\/jkms.2014.29.2.198.","journal-title":"J Korean Med Sci."},{"issue":"5","key":"1088_CR49","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/art.1780400513","volume":"40","author":"R Blanco","year":"1997","unstructured":"Blanco R, Mart\u00ednez-Taboada VM, Rodr\u00edguez-Valverde V, Garc\u00eda-Fuentes M, Gonz\u00e1lez-Gay MA. Henoch-Sch\u00f6nlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997;40(5):859\u201364. https:\/\/doi.org\/10.1002\/art.1780400513.","journal-title":"Arthritis Rheum"},{"key":"1088_CR50","doi-asserted-by":"publisher","first-page":"bcr2013202644","DOI":"10.1136\/bcr-2013-202644","volume":"2014","author":"KA Gonen","year":"2014","unstructured":"Gonen KA, Erfan G, Oznur M, Erdogan C. The first case of Henoch-Schonlein purpura associated with rosuvastatin: colonic involvement coexisting with small intestine. BMJ Case Rep. 2014;2014:bcr2013202644. https:\/\/doi.org\/10.1136\/bcr-2013-202644.","journal-title":"BMJ Case Rep."},{"issue":"1","key":"1088_CR51","doi-asserted-by":"publisher","first-page":"102707","DOI":"10.1016\/j.autrev.2020.102707","volume":"20","author":"C Rasmussen","year":"2021","unstructured":"\u2022\u2022 Rasmussen C, Tisseyre M, Garon-Czmil J, et al. Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev. 2021;20(1):102707. https:\/\/doi.org\/10.1016\/j.autrev.2020.102707. One of the largest studies reporting the most common drugs associated with IgA vasculitis.","journal-title":"Autoimmun Rev."},{"issue":"2","key":"1088_CR52","first-page":"135","volume":"36 Suppl 111","author":"O Karadag","year":"2018","unstructured":"Karadag O, Jayne DJ. Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda. Clin Exp Rheumatol. 2018;36 Suppl 111(2):135\u201342.","journal-title":"Clin Exp Rheumatol."},{"issue":"8","key":"1088_CR53","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1365-4632.2011.05074.x","volume":"52","author":"M Contreras-Steyls","year":"2013","unstructured":"Contreras-Steyls M, L\u00f3pez-Navarro N, Gallego E, Moyano B, Estrada D, Herrera E. Gemcitabine therapy-associated cutaneous vasculitis with a polyarteritis nodosa-like pattern. Int J Dermatol. 2013;52(8):1029\u201331. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05074.x.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1088_CR54","first-page":"83","volume":"30","author":"LA Weinrauch","year":"1982","unstructured":"Weinrauch LA, Belok SS, Gauvin GP, D\u2019Elia JA. Palpable acute necrotizing arteritis secondary to metolazone. Cutis. 1982;30(1):83\u20134.","journal-title":"Cutis"},{"issue":"5","key":"1088_CR55","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/1203475418760457","volume":"22","author":"D To","year":"2018","unstructured":"To D, Bradshaw S, Lipson J. Case report of empagliflozin-induced cutaneous polyarteritis nodosa. J Cutan Med Surg. 2018;22(5):516\u20138. https:\/\/doi.org\/10.1177\/1203475418760457.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"1088_CR56","first-page":"129","volume":"64","author":"D Chochrad","year":"1997","unstructured":"Chochrad D, Langhendries JP, Stolear JC, Godin J. Isotretinoin-induced vasculitis imitating polyarteritis nodosa, with perinuclear antineutrophil cytoplasmic antibody in titers correlated with clinical symptoms. Rev Rhum Engl Ed. 1997;64(2):129\u201331.","journal-title":"Rev Rhum Engl Ed"},{"issue":"5","key":"1088_CR57","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1684\/ejd.2013.2160","volume":"23","author":"S Shibata","year":"2013","unstructured":"Shibata S, Asano Y, Sato S. Cutaneous polyarteritis nodosa localized to the arm receiving an infusion of abatacept. Eur J Dermatol EJD. 2013;23(5):738\u20139. https:\/\/doi.org\/10.1684\/ejd.2013.2160.","journal-title":"Eur J Dermatol EJD"},{"issue":"2","key":"1088_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.semarthrit.2012.03.006","volume":"42","author":"TA Kermani","year":"2012","unstructured":"\u2022\u2022 Kermani TA, Ham EK, Camilleri MJ, Warrington KJ. Polyarteritis nodosa-like vasculitis in association with minocycline use: a single-center case series. Semin Arthritis Rheum. 2012;42(2):213\u201321. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.03.006. Largest case series to date, of 9 patients with polyarteritis nodosa-like vascuiltis in association with minocycline therapy.","journal-title":"Semin Arthritis Rheum."},{"issue":"6","key":"1088_CR59","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/s0002-9343(98)00325-8","volume":"105","author":"O Elkayam","year":"1998","unstructured":"Elkayam O, Levartovsky D, Brautbar C, et al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med. 1998;105(6):484\u20137. https:\/\/doi.org\/10.1016\/s0002-9343(98)00325-8.","journal-title":"Am J Med"},{"issue":"2","key":"1088_CR60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1542\/peds.103.2.503","volume":"103","author":"BJ Schrodt","year":"1999","unstructured":"Schrodt BJ, Callen JP. Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics. 1999;103(2):503\u20134. https:\/\/doi.org\/10.1542\/peds.103.2.503.","journal-title":"Pediatrics"},{"issue":"5","key":"1088_CR61","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/00007611-199905000-00010","volume":"92","author":"BJ Schrodt","year":"1999","unstructured":"Schrodt BJ, Kulp-Shorten CL, Callen JP. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J. 1999;92(5):502\u20134. https:\/\/doi.org\/10.1097\/00007611-199905000-00010.","journal-title":"South Med J"},{"issue":"2","key":"1088_CR62","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1067\/mjd.2001.112218","volume":"44","author":"JV Schaffer","year":"2001","unstructured":"Schaffer JV, Davidson DM, McNiff JM, Bolognia JL. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol. 2001;44(2):198\u2013206. https:\/\/doi.org\/10.1067\/mjd.2001.112218.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1088_CR63","first-page":"396","volume":"13","author":"F Pelletier","year":"2003","unstructured":"Pelletier F, Puzenat E, Blanc D, Faivre B, Humbert P, Aubin F. Minocycline-induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol EJD. 2003;13(4):396\u20138.","journal-title":"Eur J Dermatol EJD"},{"issue":"3","key":"1088_CR64","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/art.21186","volume":"53","author":"B Culver","year":"2005","unstructured":"Culver B, Itkin A, Pischel K. Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum. 2005;53(3):468\u201370. https:\/\/doi.org\/10.1002\/art.21186.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1088_CR65","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3109\/s10165-006-0492-4","volume":"16","author":"Y Katada","year":"2006","unstructured":"Katada Y, Harada Y, Azuma N, et al. Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Mod Rheumatol. 2006;16(4):256\u20139. https:\/\/doi.org\/10.3109\/s10165-006-0492-4.","journal-title":"Mod Rheumatol"},{"issue":"5","key":"1088_CR66","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/art.22242","volume":"55","author":"S Abad","year":"2006","unstructured":"Abad S, Kambouchner M, Nejjari M, Dhote R. Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al. Arthritis Rheum. 2006;55(5):831. https:\/\/doi.org\/10.1002\/art.22242.","journal-title":"Arthritis Rheum."},{"issue":"3","key":"1088_CR67","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/RHU.0b013e3180690693","volume":"13","author":"R Tehrani","year":"2007","unstructured":"Tehrani R, Nash-Goelitz A, Adams E, Dahiya M, Eilers D. Minocycline-induced cutaneous polyarteritis nodosa. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2007;13(3):146\u20139. https:\/\/doi.org\/10.1097\/RHU.0b013e3180690693.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"5 Suppl 1","key":"1088_CR68","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.jaad.2007.05.032","volume":"58","author":"RC Gait","year":"2008","unstructured":"Gait RC, Affleck AG, Leach IH, Varma S. Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J Am Acad Dermatol. 2008;58(5 Suppl 1):S123-124. https:\/\/doi.org\/10.1016\/j.jaad.2007.05.032.","journal-title":"J Am Acad Dermatol"},{"key":"1088_CR69","doi-asserted-by":"publisher","first-page":"bcr2012006503","DOI":"10.1136\/bcr-2012-006503","volume":"2012","author":"H Tabriziani","year":"2012","unstructured":"Tabriziani H, Wilcox CS, Gilbert ON, Lipkowitz MS. Minocycline-induced renal polyarteritis nodosa. BMJ Case Rep. 2012;2012:bcr2012006503. https:\/\/doi.org\/10.1136\/bcr-2012-006503.","journal-title":"BMJ Case Rep."},{"issue":"5","key":"1088_CR70","first-page":"322","volume":"16","author":"T Agur","year":"2014","unstructured":"Agur T, Levy Y, Plotkin E, Benchetrit S. Minocycline-induced polyarteritis nodosa-like vasculitis. Isr Med Assoc J IMAJ. 2014;16(5):322\u20133.","journal-title":"Isr Med Assoc J IMAJ"},{"issue":"3","key":"1088_CR71","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1111\/ijd.13386","volume":"56","author":"P Barnes","year":"2017","unstructured":"Barnes P, Chapman C, Fett N. Painful subcutaneous nodules in a patch of livedo reticularis. Int J Dermatol. 2017;56(3):e44\u20136. https:\/\/doi.org\/10.1111\/ijd.13386.","journal-title":"Int J Dermatol"},{"issue":"2","key":"1088_CR72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/24725625.2020.1738983","volume":"4","author":"H Kawahara","year":"2020","unstructured":"Kawahara H, Nakashima A, Zoshima T, Kawano M. Contribution of HLA-DRB1 * 09: 01 allele to development of minocycline induced antineutrophil cytoplasmic antibody (ANCA)-associated cutaneous vasculitis: report of two cases. Mod Rheumatol Case Rep. 2020;4(2):267\u201371. https:\/\/doi.org\/10.1080\/24725625.2020.1738983.","journal-title":"Mod Rheumatol Case Rep"},{"issue":"1","key":"1088_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2169\/internalmedicine.7340-21","volume":"61","author":"K Yokota","year":"2022","unstructured":"Yokota K, Kurihara I, Nakamura T, et al. Remission of angiographically confirmed minocycline-induced renal polyarteritis nodosa: a case report and literature review. Intern Med Tokyo Jpn. 2022;61(1):103\u201310. https:\/\/doi.org\/10.2169\/internalmedicine.7340-21.","journal-title":"Intern Med Tokyo Jpn"},{"issue":"3","key":"1088_CR74","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamapediatrics.2013.3763","volume":"168","author":"A Odhav","year":"2014","unstructured":"Odhav A, Odhav C, Dayal NA. Rare adverse effect of treatment with minocycline Minocycline-induced cutaneous polyarteritis nodosa. JAMA Pediatr. 2014;168(3):287\u20138. https:\/\/doi.org\/10.1001\/jamapediatrics.2013.3763.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"1088_CR75","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.07828.x","volume":"156","author":"H Marzo-Ortega","year":"2007","unstructured":"Marzo-Ortega H, Baxter K, Strauss RM, et al. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br J Dermatol. 2007;156(5):1005\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07828.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1088_CR76","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-2133.2000.03357.x","volume":"142","author":"J Dunphy","year":"2000","unstructured":"Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol. 2000;142(3):461\u20137. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03357.x.","journal-title":"Br J Dermatol"},{"issue":"5186","key":"1088_CR77","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.7973636","volume":"266","author":"X Jiang","year":"1994","unstructured":"Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science. 1994;266(5186):810\u20133. https:\/\/doi.org\/10.1126\/science.7973636.","journal-title":"Science"},{"issue":"7","key":"1088_CR78","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI15918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110(7):955\u201363. https:\/\/doi.org\/10.1172\/JCI15918.","journal-title":"J Clin Invest"},{"issue":"1","key":"1088_CR79","doi-asserted-by":"publisher","first-page":"rkaa004","DOI":"10.1093\/rap\/rkaa004","volume":"4","author":"K Taimen","year":"2020","unstructured":"\u2022\u2022 Taimen K, Heino S, Kohonen I, et al. Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review. Rheumatol Adv Pract. 2020;4(1):rkaa004. https:\/\/doi.org\/10.1093\/rap\/rkaa004. Retrospective study and literature review reporting the association between LVV, G-CSF and chemotherapy.","journal-title":"Rheumatol Adv Pract."},{"issue":"2","key":"1088_CR80","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/24725625.2020.1857022","volume":"5","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto K, Tamura N, Oka K, et al. Large-vessel vasculitis induced by granulocyte colony-stimulating factor administration after chemotherapy. Mod Rheumatol Case Rep. 2021;5(2):322\u20136. https:\/\/doi.org\/10.1080\/24725625.2020.1857022.","journal-title":"Mod Rheumatol Case Rep"},{"issue":"4","key":"1088_CR81","first-page":"355","volume":"46","author":"R Costa Silva","year":"2021","unstructured":"Costa Silva R, Monteiro M, Dias RP, et al. Large-vessel vasculitis induced by pegfilgrastim. Acta Reumatol Port. 2021;46(4):355\u20139.","journal-title":"Acta Reumatol Port"},{"issue":"5","key":"1088_CR82","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tjog.2018.08.026","volume":"57","author":"K Hiranuma","year":"2018","unstructured":"Hiranuma K, Kusunoki S, Fujino K, Hirayama T, Ota T, Terao Y. Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy. Taiwan J Obstet Gynecol. 2018;57(5):750\u20132. https:\/\/doi.org\/10.1016\/j.tjog.2018.08.026.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"1088_CR83","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/03009742.2017.1314005","volume":"47","author":"S Fukui","year":"2018","unstructured":"Fukui S, Iwamoto N, Kawakami A. Drug-induced large vessel vasculitis with carotid arterial ring sign. Scand J Rheumatol. 2018;47(1):83\u20134. https:\/\/doi.org\/10.1080\/03009742.2017.1314005.","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"1088_CR84","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3899\/jrheum.200023","volume":"47","author":"C Mettler","year":"2020","unstructured":"\u2022\u2022 Mettler C, Chouchana L, Terrier B. Antineoplastic drug-induced aortitis: an unraveled adverse effect using the World Health Organization Pharmacovigilance Database. J Rheumatol. 2020;47(8):1298\u2013300. https:\/\/doi.org\/10.3899\/jrheum.200023. Report from the World Health Organization database regarding antineoplastic drug-induced aortitis and large vessel vasculitis.","journal-title":"J Rheumatol."},{"issue":"5","key":"1088_CR85","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/ejcts\/ezx165","volume":"52","author":"Y Sato","year":"2017","unstructured":"Sato Y, Kaji S, Ueda H, Tomii K. Thoracic aortitis and aortic dissection following pegfilgrastim administration. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2017;52(5):993\u20134. https:\/\/doi.org\/10.1093\/ejcts\/ezx165.","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"issue":"4","key":"1088_CR86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/RHU.0b013e3181df91ad","volume":"16","author":"LB Ramsay","year":"2010","unstructured":"Ramsay LB, Stany MP, Edison JD, Bernstein SA, Schlegal KE, Hamilton CA. Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2010;16(4):181\u20132. https:\/\/doi.org\/10.1097\/RHU.0b013e3181df91ad.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"14","key":"1088_CR87","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.2217\/fon.15.111","volume":"11","author":"A Chan","year":"2015","unstructured":"Chan A, Song M, De Guzman Langit MR, et al. Carotid artery inflammation associated with gemcitabine-based therapy: a special report. Future Oncol Lond Engl. 2015;11(14):2049\u201358. https:\/\/doi.org\/10.2217\/fon.15.111.","journal-title":"Future Oncol Lond Engl"},{"issue":"24","key":"1088_CR88","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1161\/CIRCULATIONAHA.120.048708","volume":"142","author":"R Calabretta","year":"2020","unstructured":"Calabretta R, Hoeller C, Pichler V, et al. Immune Checkpoint inhibitor therapy induces inflammatory activity in large arteries. Circulation. 2020;142(24):2396\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048708.","journal-title":"Circulation"},{"issue":"5","key":"1088_CR89","doi-asserted-by":"publisher","first-page":"H1052","DOI":"10.1152\/ajpheart.00024.2017","volume":"312","author":"R Watanabe","year":"2017","unstructured":"Watanabe R, Zhang H, Berry G, Goronzy JJ, Weyand CM. Immune checkpoint dysfunction in large and medium vessel vasculitis. Am J Physiol Heart Circ Physiol. 2017;312(5):H1052\u20139. https:\/\/doi.org\/10.1152\/ajpheart.00024.2017.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1088_CR90","doi-asserted-by":"publisher","unstructured":"Zhang H, Watanabe R, Berry GJ, et al. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis. Proc Natl Acad Sci. 2017;114(6). https:\/\/doi.org\/10.1073\/pnas.1616848114.","DOI":"10.1073\/pnas.1616848114"},{"issue":"9","key":"1088_CR91","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s10067-018-4177-0","volume":"37","author":"A Daxini","year":"2018","unstructured":"\u2022\u2022 Daxini A, Cronin K, Sreih AG. Vasculitis associated with immune checkpoint inhibitors-a systematic review. Clin Rheumatol. 2018;37(9):2579\u201384. https:\/\/doi.org\/10.1007\/s10067-018-4177-0. Systematic review that assessed the occurrence and nature of vasculitis associated with cancer treatment using immune checkpoint inhibitors. Most common type of vasculitis was large vessel vasculitis and vasculitis of the central and peripheral nervous system.","journal-title":"Clin Rheumatol."},{"issue":"6","key":"1088_CR92","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11926-019-0828-7","volume":"21","author":"TM Crout","year":"2019","unstructured":"\u2022\u2022 Crout TM, Lennep DS, Kishore S, Majithia V. Systemic vasculitis associated with immune check point inhibition: analysis and review. Curr Rheumatol Rep. 2019;21(6):28. https:\/\/doi.org\/10.1007\/s11926-019-0828-7. Review that focused on the development of vasculitis with the use of immune checkpoint inhibitors.","journal-title":"Curr Rheumatol Rep."},{"issue":"11","key":"1088_CR93","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.3899\/jrheum.140390","volume":"41","author":"F Ortiz-Sanju\u00e1n","year":"2014","unstructured":"\u2022\u2022 Ortiz-Sanju\u00e1n F, Blanco R, Hern\u00e1ndez JL, et al. Drug-associated cutaneous vasculitis: study of 239 patients from a single referral center. J Rheumatol. 2014;41(11):2201\u20137. https:\/\/doi.org\/10.3899\/jrheum.140390. Large single center study describing 239 patients with drug-associated cutaneous vasculitis. antibiotics and NSAIDs were the most commonly associated drugs.","journal-title":"J Rheumatol."},{"issue":"7","key":"1088_CR94","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s00520-018-4052-1","volume":"26","author":"A Alloo","year":"2018","unstructured":"Alloo A, Khosravi H, Granter SR, et al. Ixazomib-induced cutaneous necrotizing vasculitis. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2018;26(7):2247\u201350. https:\/\/doi.org\/10.1007\/s00520-018-4052-1.","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"3","key":"1088_CR95","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/1078155219862342","volume":"26","author":"U Kulkarni","year":"2020","unstructured":"Kulkarni U, Nayak V, Prabhu MM, Rao R. Tamoxifen-induced vasculitis. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract. 2020;26(3):735\u20137. https:\/\/doi.org\/10.1177\/1078155219862342.","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"issue":"1","key":"1088_CR96","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1203475420943260","volume":"25","author":"A Muntyanu","year":"2021","unstructured":"Muntyanu A, Netchiporouk E, Gerstein W, Gniadecki R, Litvinov IV. Cutaneous Immune-related adverse events (irAEs) to immune checkpoint inhibitors: a dermatology perspective on management [Formula: see text]. J Cutan Med Surg. 2021;25(1):59\u201376. https:\/\/doi.org\/10.1177\/1203475420943260.","journal-title":"J Cutan Med Surg"},{"key":"1088_CR97","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.ejim.2018.07.023","volume":"57","author":"A Tomelleri","year":"2018","unstructured":"Tomelleri A, Campochiaro C, De Luca G, Cavalli G, Dagna L. Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: a case series. Eur J Intern Med. 2018;57:e11\u20132. https:\/\/doi.org\/10.1016\/j.ejim.2018.07.023.","journal-title":"Eur J Intern Med"},{"issue":"17","key":"1088_CR98","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/ajhp\/zxaa182","volume":"77","author":"B Daul","year":"2020","unstructured":"Daul B, Petersen G, Butler J. Possible apixaban-induced leukocytoclastic vasculitis. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2020;77(17):1389\u201392. https:\/\/doi.org\/10.1093\/ajhp\/zxaa182.","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"issue":"3","key":"1088_CR99","first-page":"148","volume":"91","author":"T Lazic","year":"2013","unstructured":"Lazic T, Fonder M, Robinson-Bostom L, Wilkel CS, Della TL. Orlistat-induced bullous leukocytoclastic vasculitis. Cutis. 2013;91(3):148\u20139.","journal-title":"Cutis"},{"issue":"6","key":"1088_CR100","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/tropej\/fmt048","volume":"59","author":"V Bhatia","year":"2013","unstructured":"Bhatia V, Sibal A, Rajgarhia S. Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis. J Trop Pediatr. 2013;59(6):507\u20138. https:\/\/doi.org\/10.1093\/tropej\/fmt048.","journal-title":"J Trop Pediatr"},{"issue":"713","key":"1088_CR101","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/pgmj.61.713.245","volume":"61","author":"M St\u00e4ubli","year":"1985","unstructured":"St\u00e4ubli M, Zimmermann A, Bircher J. Amiodarone-induced vasculitis and polyserositis. Postgrad Med J. 1985;61(713):245\u20137. https:\/\/doi.org\/10.1136\/pgmj.61.713.245.","journal-title":"Postgrad Med J"},{"issue":"1","key":"1088_CR102","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2230.2008.03014.x","volume":"34","author":"F Corella","year":"2009","unstructured":"Corella F, Dalmau J, Ro\u00e9 E, Garc\u00eda-Navarro X, Alomar A. Cutaneous vasculitis associated with gemcitabine therapy. Clin Exp Dermatol. 2009;34(1):97\u20139. https:\/\/doi.org\/10.1111\/j.1365-2230.2008.03014.x.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"1088_CR103","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/00015550310007544","volume":"83","author":"MS Luong","year":"2003","unstructured":"Luong MS, Bessis D, Raison-Peyron N, Pinzani V, Guilhou JJ, Guillot B. Severe mucocutaneous necrotizing vasculitis associated with the combination of chloroquine and proguanil. Acta Derm Venereol. 2003;83(2):141. https:\/\/doi.org\/10.1080\/00015550310007544.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"1088_CR104","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","volume":"22","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol. 2008;22(5):847\u201361. https:\/\/doi.org\/10.1016\/j.berh.2008.09.008.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1088_CR105","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007;86(4):242\u201351. https:\/\/doi.org\/10.1097\/MD.0b013e3181441a68.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1088_CR106","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1136\/ard.2006.051888","volume":"65","author":"M De Bandt","year":"2006","unstructured":"De Bandt M, Saint-Marcoux B, on behalf of the CRI (Club Rhumatismes et Inflammation). Tumour necrosis factor blockade and the risk of vasculitis. Ann Rheum Dis. 2006;65(11):1534\u20135. https:\/\/doi.org\/10.1136\/ard.2006.051888.","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"1088_CR107","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.mayocp.2012.04.011","volume":"87","author":"O Sokumbi","year":"2012","unstructured":"Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors. Mayo Clin Proc. 2012;87(8):739\u201345. https:\/\/doi.org\/10.1016\/j.mayocp.2012.04.011.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1088_CR108","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncprheum0708","volume":"4","author":"AB Mongey","year":"2008","unstructured":"Mongey AB, Hess EV. Drug insight: autoimmune effects of medications-what\u2019s new? Nat Clin Pract Rheumatol. 2008;4(3):136\u201344. https:\/\/doi.org\/10.1038\/ncprheum0708.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"6","key":"1088_CR109","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/13550289809114228","volume":"4","author":"L Zhang","year":"1998","unstructured":"Zhang L, Looney D, Taub D, et al. Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol. 1998;4(6):619\u201326. https:\/\/doi.org\/10.3109\/13550289809114228.","journal-title":"J Neurovirol"},{"issue":"1","key":"1088_CR110","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00005792-198801000-00002","volume":"67","author":"LH Calabrese","year":"1988","unstructured":"Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore). 1988;67(1):20\u201339. https:\/\/doi.org\/10.1097\/00005792-198801000-00002.","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"1088_CR111","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1227\/00006123-198706000-00027","volume":"20","author":"R Glick","year":"1987","unstructured":"Glick R, Hoying J, Cerullo L, Perlman S. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage Case report and review. Neurosurgery. 1987;20(6):969\u201374. https:\/\/doi.org\/10.1227\/00006123-198706000-00027.","journal-title":"Neurosurgery"},{"issue":"19","key":"1088_CR112","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJM197011052831901","volume":"283","author":"BP Citron","year":"1970","unstructured":"Citron BP, Halpern M, McCarron M, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med. 1970;283(19):1003\u201311. https:\/\/doi.org\/10.1056\/NEJM197011052831901.","journal-title":"N Engl J Med"},{"issue":"7","key":"1088_CR113","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1212\/wnl.40.7.1092","volume":"40","author":"DA Krendel","year":"1990","unstructured":"Krendel DA, Ditter SM, Frankel MR, Ross WK. Biopsy-proven cerebral vasculitis associated with cocaine abuse. Neurology. 1990;40(7):1092\u20134. https:\/\/doi.org\/10.1212\/wnl.40.7.1092.","journal-title":"Neurology"},{"issue":"11","key":"1088_CR114","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1161\/01.str.22.11.1437","volume":"22","author":"RK Fredericks","year":"1991","unstructured":"Fredericks RK, Lefkowitz DS, Challa VR, Troost BT. Cerebral vasculitis associated with cocaine abuse. Stroke. 1991;22(11):1437\u20139. https:\/\/doi.org\/10.1161\/01.str.22.11.1437.","journal-title":"Stroke"},{"key":"1088_CR115","doi-asserted-by":"crossref","unstructured":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27\u20131993. A 32-year-old man with the sudden onset of a right-sided headache and left hemiplegia and hemianesthesia. N Engl J Med. 1993;329(2):117\u2013124. https:\/\/doi.org\/10.1056\/NEJM199307083290209","DOI":"10.1056\/NEJM199307083290209"},{"issue":"3","key":"1088_CR116","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/s0049-0172(95)80029-8","volume":"25","author":"PA Merkel","year":"1995","unstructured":"Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum. 1995;25(3):172\u201383. https:\/\/doi.org\/10.1016\/s0049-0172(95)80029-8.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1088_CR117","first-page":"147","volume":"27","author":"N Mart\u00ednez","year":"1996","unstructured":"Mart\u00ednez N, D\u00edez-Tejedor E, Frank A. Vasospasm\/thrombus in cerebral ischemia related to cocaine abuse. Stroke. 1996;27(1):147\u20138.","journal-title":"Stroke"},{"key":"1088_CR118","doi-asserted-by":"crossref","unstructured":"Diez-Tejedor null, Frank null, Gutierrez null, Barreiro null. Encephalopathy and biopsy-proven cerebrovascular inflammatory changes in a cocaine abuser. Eur J Neurol. 1998;5(1):103\u2013107. https:\/\/doi.org\/10.1046\/j.1468-1331.1998.510103.x","DOI":"10.1046\/j.1468-1331.1998.510103.x"},{"issue":"3","key":"1088_CR119","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1520\/JFS13463J","volume":"38","author":"PL Morrow","year":"1993","unstructured":"Morrow PL, McQuillen JB. Cerebral vasculitis associated with cocaine abuse. J Forensic Sci. 1993;38(3):732\u20138.","journal-title":"J Forensic Sci"},{"issue":"1","key":"1088_CR120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/CPJ.0000000000000324","volume":"7","author":"MA Topcuoglu","year":"2017","unstructured":"Topcuoglu MA, Jha RM, George J, Frosch MP, Singhal AB. Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure. Neurol Clin Pract. 2017;7(1):26\u201334. https:\/\/doi.org\/10.1212\/CPJ.0000000000000324.","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"1088_CR121","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246401","volume":"15","author":"NK Sim","year":"2022","unstructured":"Sim NK, Ismail A, Alam T, Shanmugarajah PD. Adalimumab-induced sensory vasculitic neuropathy. BMJ Case Rep. 2022;15(1): e246401. https:\/\/doi.org\/10.1136\/bcr-2021-246401.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1088_CR122","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/annonc\/mdw613","volume":"28","author":"F Aya","year":"2017","unstructured":"Aya F, Ruiz-Esquide V, Viladot M, et al. Vasculitic neuropathy induced by pembrolizumab. Ann Oncol Off J Eur Soc Med Oncol. 2017;28(2):433\u20134. https:\/\/doi.org\/10.1093\/annonc\/mdw613.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"10","key":"1088_CR123","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1001\/jamaneurol.2017.1912","volume":"74","author":"JC Kao","year":"2017","unstructured":"Kao JC, Liao B, Markovic SN, et al. Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurol. 2017;74(10):1216\u201322. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1912.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1088_CR124","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1468-1331.2010.03041.x","volume":"18","author":"AFJE Vrancken","year":"2011","unstructured":"Vrancken AFJE, Gathier CS, Cats EA, Notermans NC, Collins MP. The additional yield of combined nerve\/muscle biopsy in vasculitic neuropathy. Eur J Neurol. 2011;18(1):49\u201358. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03041.x.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1088_CR125","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1085-9489.2006.00060.x","volume":"11","author":"C Vital","year":"2006","unstructured":"Vital C, Vital A, Canron MH, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst JPNS. 2006;11(1):20\u20139. https:\/\/doi.org\/10.1111\/j.1085-9489.2006.00060.x.","journal-title":"J Peripher Nerv Syst JPNS."},{"issue":"3","key":"1088_CR126","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/CND.0000000000000197","volume":"19","author":"MK Kang","year":"2018","unstructured":"Kang MK, Gupta RK, Srinivasan J. Peripheral vasculitic neuropathy associated with minocycline use. J Clin Neuromuscul Dis. 2018;19(3):138\u201341. https:\/\/doi.org\/10.1097\/CND.0000000000000197.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"1","key":"1088_CR127","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000180","volume":"3","author":"JM Baratta","year":"2016","unstructured":"Baratta JM, Dyck PJB, Brand P, et al. Vasculitic neuropathy following exposure to minocycline. Neurol Neuroimmunol Neuroinflammation. 2016;3(1): e180. https:\/\/doi.org\/10.1212\/NXI.0000000000000180.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"8","key":"1088_CR128","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.24634","volume":"73","author":"SA Chung","year":"2021","unstructured":"\u2022\u2022 Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res. 2021;73(8):1088\u2013105. https:\/\/doi.org\/10.1002\/acr.24634. American College of Rheumatology\/Vasculitis Foundation latest guidelines on the management of AAV.","journal-title":"Arthritis Care Res."},{"issue":"8","key":"1088_CR129","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/acr.24633","volume":"73","author":"SA Chung","year":"2021","unstructured":"\u2022\u2022 Chung SA, Gorelik M, Langford CA, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Care Res. 2021;73(8):1061\u201370. https:\/\/doi.org\/10.1002\/acr.24633. American College of Rheumatology\/Vasculitis foundation latest guidelines on the management of polyarteritis nodosa.","journal-title":"Arthritis Care Res."},{"issue":"8","key":"1088_CR130","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/acr.24632","volume":"73","author":"M Maz","year":"2021","unstructured":"\u2022\u2022 Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Care Res. 2021;73(8):1071\u201387. https:\/\/doi.org\/10.1002\/acr.24632. American College of Rheumatology\/Vasculitis foundation latest guidelines on the management of Giant Cell Arteritis and Takayasu Arteritis.","journal-title":"Arthritis Care Res."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-022-01088-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-022-01088-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-022-01088-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T08:44:25Z","timestamp":1665132265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-022-01088-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":130,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1088"],"URL":"https:\/\/doi.org\/10.1007\/s11926-022-01088-0","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"16 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}